Market Overview

The global immunoassay market was valued at USD 32.6 Billion in 2024 and is projected to reach USD 51.5 Billion by 2033, growing at a CAGR of 4.78% during the forecast period from 2025 to 2033. Immunoassays are critical analytical techniques used for detecting analytes with antibodies or antigens in clinical diagnostics, pharmaceutical analysis, and food safety, among others. The market's growth is driven by rising chronic and infectious diseases and innovations such as smartphone-based diagnostics.

Study Assumption Years

• Base Year: 2024
• Historical Year/Period: 2019-2024
• Forecast Year/Period: 2025-2033

Immunoassay Market Key Takeaways

• The global immunoassay market size was USD 32.6 Billion in 2024.
• The market is expected to grow at a CAGR of 4.78% during 2025-2033.
• Forecast market size is USD 51.5 Billion by 2033.
• Immunoassays are used extensively in clinical and pharmaceutical diagnostics as well as environmental monitoring.
• The technology is replacing conventional tests such as HPLC and GC in food contamination analysis due to its speed and cost-effectiveness.
• Advancements include development in surface plasmon resonance instruments, microfluidics, biosensors, and smartphone-based assay formats.
• Increasing global prevalence of chronic and infectious diseases is a significant growth driver.

Sample Request Link: https://www.imarcgroup.com/immunoassay-market/requestsample

Market Growth Factors

The immunoassay market growth is principally driven by the increasing global burden of chronic and infectious diseases. The technology facilitates high specificity, sensitivity, and throughput in disease diagnosis, therapeutic drug monitoring, and clinical pharmacokinetics, supporting pharmaceutical analysis and drug discovery worldwide. This widespread utility across healthcare is a fundamental factor pushing the market forward.

Another growth factor is the rapid replacement of traditional diagnostic methods with immunoassays due to their rapidity, simplicity, and cost effectiveness. Immunoassays are increasingly preferred over conventional methods such as high-performance liquid chromatography (HPLC) and gas chromatography (GC), especially for on-site food contamination analysis. This substitution trend enhances the demand for immunoassays in food safety testing.

Innovations in immunoanalytical systems also contribute to market expansion. Research into biosensor technologies, microfluidics, bioengineering, and surface plasmon resonance (SPR) instruments is yielding advanced analytical approaches. The emergence of smartphone-based immunoassay formats and multiplex bead assays enables real-time health monitoring and in vitro diagnostics, accelerating the adoption of immunoassays in healthcare, research, and agriculture sectors.

Market Segmentation

• Breakup by Technology: Radioimmunoassay, Enzyme Immunoassay, Rapid Test, Others. Technologies offer specific antibody/antigen based detection methods critical to various diagnostic applications.
• Breakup by Product: Reagents and Kits, Analyzers/Instruments, Software and Services. These products support immunoassay testing with comprehensive solutions for detection and analysis.
• Breakup by Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Others. Diverse medical fields utilize immunoassays for precise biomarker detection and monitoring.
• Breakup by End Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, Others. These end users implement immunoassays for diagnosis, research, and drug development purposes.
• Breakup by Region: North America (United States, Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others), Latin America (Brazil, Mexico, Others), Middle East and Africa.

Regional Insights

North America is a dominant region in the immunoassay market, supported by the presence of major healthcare infrastructure and demand for advanced diagnostic testing. The report covers regions including Asia Pacific, Europe, Latin America, and Middle East & Africa, highlighting the broad global presence and adoption of immunoassay technologies.

Key Players

• Abbott
• Becton Dickinson and Company
• BioM 09rieux SA
• Danaher Corporation
• Merck KGaA
• PerkinElmer Inc
• Quidel Corporation
• Siemens Healthcare Pty Ltd (Siemens AG)
• Sysmex Corporation
• Thermo Fisher Scientific

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

?Get Custom Market Research for Your Business?

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302